curl --request GET \
  --url https://api.pav.bio/v1/deals/{deal_id} \
  --header 'Authorization: Bearer <token>'

import requests

url = "https://api.pav.bio/v1/deals/{deal_id}"

headers = {"Authorization": "Bearer <token>"}

response = requests.get(url, headers=headers)

print(response.text)

const options = {method: 'GET', headers: {Authorization: 'Bearer <token>'}};

fetch('https://api.pav.bio/v1/deals/{deal_id}', options)
  .then(res => res.json())
  .then(res => console.log(res))
  .catch(err => console.error(err));

package main

import (
	"fmt"
	"net/http"
	"io"
)

func main() {

	url := "https://api.pav.bio/v1/deals/{deal_id}"

	req, _ := http.NewRequest("GET", url, nil)

	req.Header.Add("Authorization", "Bearer <token>")

	res, _ := http.DefaultClient.Do(req)

	defer res.Body.Close()
	body, _ := io.ReadAll(res.Body)

	fmt.Println(string(body))

}

{
  "deal_id": "ec0bcf74-fdc0-4ffa-ad04-fe25ed8d6210",
  "deal_name": "Merck KGaA acquisition of Bio-Techne Corporation",
  "deal_type": "acquisition",
  "latest_event_type": "completed",
  "latest_event_name": "<string>",
  "summary": "<string>",
  "source_document_count": 123,
  "event_count": 123,
  "terms": {
    "headline_value": {
      "raw_text": "total enterprise value of approximately US$11.3 billion",
      "amount": 11300000000,
      "currency": "USD",
      "percentage": null,
      "not_disclosed": false,
      "evidence": "<string>"
    },
    "total_potential_value": {
      "raw_text": "total enterprise value of approximately US$11.3 billion",
      "amount": 11300000000,
      "currency": "USD",
      "percentage": null,
      "not_disclosed": false,
      "evidence": "<string>"
    },
    "upfront": {
      "raw_text": "total enterprise value of approximately US$11.3 billion",
      "amount": 11300000000,
      "currency": "USD",
      "percentage": null,
      "not_disclosed": false,
      "evidence": "<string>"
    },
    "equity": {
      "raw_text": "total enterprise value of approximately US$11.3 billion",
      "amount": 11300000000,
      "currency": "USD",
      "percentage": null,
      "not_disclosed": false,
      "evidence": "<string>"
    },
    "milestones": {
      "raw_text": "total enterprise value of approximately US$11.3 billion",
      "amount": 11300000000,
      "currency": "USD",
      "percentage": null,
      "not_disclosed": false,
      "evidence": "<string>"
    },
    "royalties": {
      "raw_text": "total enterprise value of approximately US$11.3 billion",
      "amount": 11300000000,
      "currency": "USD",
      "percentage": null,
      "not_disclosed": false,
      "evidence": "<string>"
    },
    "territories": [
      "<string>"
    ],
    "rights_summary": "<string>"
  },
  "latest_event_at": "2023-11-07T05:31:56Z",
  "activity_date": "2023-11-07T05:31:56Z",
  "announced_at": "2023-11-07T05:31:56Z",
  "latest_update_at": "2023-11-07T05:31:56Z",
  "completed_at": "2023-11-07T05:31:56Z",
  "companies": [
    {
      "company_id": 239,
      "short_name": "merck_kgaa",
      "name": "Merck KGaA",
      "roles": [
        "acquirer"
      ]
    }
  ],
  "total_value": {
    "raw_text": "total enterprise value of approximately US$11.3 billion",
    "amount": 11300000000,
    "currency": "USD",
    "percentage": null,
    "not_disclosed": false,
    "evidence": "<string>"
  },
  "total_potential_value": {
    "raw_text": "total enterprise value of approximately US$11.3 billion",
    "amount": 11300000000,
    "currency": "USD",
    "percentage": null,
    "not_disclosed": false,
    "evidence": "<string>"
  },
  "upfront": {
    "raw_text": "total enterprise value of approximately US$11.3 billion",
    "amount": 11300000000,
    "currency": "USD",
    "percentage": null,
    "not_disclosed": false,
    "evidence": "<string>"
  },
  "development_milestones": {
    "raw_text": "total enterprise value of approximately US$11.3 billion",
    "amount": 11300000000,
    "currency": "USD",
    "percentage": null,
    "not_disclosed": false,
    "evidence": "<string>"
  },
  "regulatory_milestones": {
    "raw_text": "total enterprise value of approximately US$11.3 billion",
    "amount": 11300000000,
    "currency": "USD",
    "percentage": null,
    "not_disclosed": false,
    "evidence": "<string>"
  },
  "commercial_milestones": {
    "raw_text": "total enterprise value of approximately US$11.3 billion",
    "amount": 11300000000,
    "currency": "USD",
    "percentage": null,
    "not_disclosed": false,
    "evidence": "<string>"
  },
  "assets": [
    {
      "drug_id": 8880,
      "name": "tulisokibart",
      "modality": "antibody",
      "program_ids": [
        3497,
        3498
      ]
    }
  ],
  "targets": [
    {
      "term_id": "NCIT:C18289",
      "term_label": "Tumor Necrosis Factor Ligand Superfamily Member 15",
      "gene_symbol": "TNFSF15"
    }
  ],
  "modalities": [
    "antibody"
  ],
  "therapeutic_areas": [
    "immunology",
    "gastroenterology"
  ],
  "events": [
    {
      "event_type": "proposed",
      "event_name": "<string>",
      "effective_at": "2023-11-07T05:31:56Z",
      "source_url": "<string>"
    }
  ],
  "source_documents": [
    {
      "source_vendor": "sec",
      "source_kind": "sec_filing",
      "source_id": "0001999371-26-013429/ex99-1.htm",
      "observed_at": "2023-11-07T05:31:56Z",
      "source_url": "<string>",
      "published_at": "2023-11-07T05:31:56Z"
    }
  ]
}

{
  "error": {
    "code": "not_found",
    "message": "program 999999 not found",
    "request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
  }
}

{
  "error": {
    "code": "not_found",
    "message": "program 999999 not found",
    "request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
  }
}

{
  "error": {
    "code": "not_found",
    "message": "program 999999 not found",
    "request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
  }
}

{
  "error": {
    "code": "not_found",
    "message": "program 999999 not found",
    "request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
  }
}